Win, Z., Hussain, A., Srinivasmurthy, R., Hattin, R., Jones, D., Nanda, R., Ta, J., Chu, T., Tun, T., Aboaid, H., Nguyen, K., Myat, Y., Chu, M., Mohib, K., Macias, A., Htwe, K. K., Thein, K. (2025). Abstract 4367292: Meta-Analysis of Phase III Randomized Controlled Trials to Evaluate the Risk of Cardiac Adverse Events in Patients with Non-small Cell Lung Cancer Treated with Osimertinib Compared to Control. Circulation. https://doi.org/10.1161/circ.152.suppl_3.4367292